Does Sevelamer reduce mortality by slowing of progression of coronary calcification?
Badve
S V
SV
Magner
P O
PO
D002114:Calcinosis / Q000517:prevention & control*; D002614:Chelating Agents / Q000008:administration & dosage*; D003331:Coronary Vessels / Q000473:pathology*; D018450:Disease Progression; D006801:Humans; D011073:Polyamines / Q000008:administration & dosage*; D006435:Renal Dialysis / Q000401:mortality*; D000069603:Sevelamer
D002614:Chelating Agents; D011073:Polyamines; D000069603:Sevelamer